Apatinib efficiently inhibited the expression of NDUFA4L2, which caused GBM cell cycle arrest, induced apoptosis, and forced cells to initiate protective mitophagy in vitro and in vivo; notably, autophagy inhibition could significantly enhance the anti-cancer effects of apatinib. This evidence concerns the gene COXFA4L2 and cancer.